How Gene Edited Chickens Could Revolutionize the Fight Against Avian Influenza

Deesha Gupta  Division of Animal Genetics & Breeding, deeshagupta9@gmail.com

 Faculty of Veterinary Sciences & Animal Husbandry, Shere-e-Kashmir University of Agricultural Sciences & Technology, Jammu, R.S. Pura – 181 102, Jammu & Kashmir, India

For decades, poultry farmers across the world have lived under the shadow of a deadly threat: avian influenza, commonly known as bird flu. This highly contagious viral disease has time and again led to devastating outbreaks, forcing the culling of millions of chickens and ducks and bringing massive economic losses. Countries like India, with a vast and varied poultry sector spanning from high-tech commercial farms to traditional backyard units, are particularly vulnerable. While existing strategies such as vaccines, biosecurity measures, and rapid outbreak response have helped to an extent, they are often limited by the rapid mutation of influenza viruses and logistical constraints in low-resource settings. Now, a groundbreaking scientific development is offering new hope in the form of gene-edited chickens that are partially resistant to bird flu. This advancement is not just another technical fix—it represents a paradigm shift in the way we think about disease control in poultry, combining the precision of modern biotechnology with practical solutions for one of the world’s most persistent animal health challenges.

CRISPR Gene Editing and the Breakthrough at the Roslin Institute

The innovation was led by scientists at the Roslin Institute of the University of Edinburgh, a research center globally renowned for its work in animal genetics. Using CRISPR-Cas9 gene editing—a tool often compared to molecular scissors—they altered a specific gene in chickens called ANP32A. This gene is important because it supports the replication of the avian influenza virus inside a bird’s cells. By making a small, precise change to this gene, the researchers were able to stop the virus from multiplying effectively, essentially closing the door on its ability to take over the chicken’s biology. In a carefully controlled trial, ten gene-edited chickens were exposed to the H9N2 strain of avian influenza, a variant common in Asia. Remarkably, nine out of ten birds remained completely free of infection, while the tenth bird showed only a low level of virus that didn’t spread to others. The result was not just statistically significant—it was a powerful demonstration of what targeted gene editing can achieve in real-world disease resistance.

Why CRISPR Stands Out from Conventional Breeding or GMO Techniques

What makes this approach especially appealing is that it does not involve introducing foreign DNA into the animal, unlike earlier forms of genetic modification. Instead, CRISPR works by making changes to the animal’s own genome, mimicking the type of genetic variation that could theoretically occur naturally, but doing so with speed and precision. This is an important distinction because it could influence how regulatory bodies and the general public perceive and accept gene-edited animals. In terms of practical outcomes, the edited chickens in the study remained healthy, grew normally, and were able to reproduce without any observed complications, suggesting that the genetic change did not have negative side effects on productivity or welfare. This raises the possibility that, in the future, gene-edited chickens could be incorporated into breeding programs on a large scale, offering a new layer of disease protection to farmers across the world.

Opportunities for Indian Poultry Systems and Backyard Farming

India stands to benefit greatly from such technology, given the unique structure of its poultry industry. While there are organized commercial farms producing broilers and layers at scale, a significant portion of the country’s poultry is still raised in small backyard systems, especially by women and marginal farmers. These birds are more exposed to wild avian species, and vaccination and surveillance in such settings are often inconsistent. In these environments, outbreaks of bird flu not only kill animals but also destabilize household income and food security. The introduction of flu-resistant chickens—especially if adapted to local breeds like Kadaknath, Aseel, or Vanaraja—could significantly reduce the frequency and severity of outbreaks. Moreover, it would alleviate the burden on public veterinary systems and reduce the need for mass culling, a strategy that is both controversial and emotionally distressing for communities who depend on their flocks.

Challenges: Mutation Risks, Policy Barriers, and Ethical Questions

However, no technology arrives without its challenges. One of the concerns raised by the researchers themselves is the possibility that the flu virus might eventually adapt to the changes in the chicken’s genome, rendering the edit less effective over time. To counter this, further modifications may be required, possibly involving related genes like ANP32B or ANP32E, which also support viral replication. This highlights the need for ongoing research and monitoring, even after gene-edited birds are released. On the regulatory front, India’s stance on gene-edited animals is still under development. While there has been some progress in approving gene-edited crops like mustard, the use of gene-editing in livestock remains a gray area. Key issues such as biosafety evaluation, labeling, traceability, and consumer acceptance will need to be addressed before gene-edited chickens can be adopted at scale.

Public Understanding and the Importance of Farmer Engagement

Another layer of complexity is public perception. Gene editing, though scientifically distinct from traditional genetic modification, is still often misunderstood. There is a need for clear communication to help consumers and farmers understand what the technology involves, how it works, and why it matters. Public institutions, especially those under the Indian Council of Agricultural Research, can play a key role here by piloting gene-edited birds in controlled field trials and involving local communities in the evaluation process. This participatory approach can ensure that the benefits of innovation are shared widely and responsibly, building trust in both the science and the systems that support it.

Stronger Poultry Means Safer Humans: The Zoonotic Perspective

As the world continues to grapple with emerging infectious diseases—many of which jump from animals to humans—the case for using cutting-edge tools like gene editing becomes stronger. Bird flu is not only a threat to poultry but also a potential zoonotic risk to people. By stopping the virus at its source—within the host species itself—we can break the chain of transmission and reduce the chances of future pandemics. While gene-edited chickens are not a silver bullet, they are a valuable addition to a larger strategy that includes surveillance, vaccination, hygiene, and responsible farm management. They represent what science can offer when it works hand in hand with real-world needs: a smarter, safer, and more resilient way to produce food and protect livelihoods.

Conclusion: A Future-Proof Strategy in Poultry Breeding

In conclusion, the development of gene-edited, flu-resistant chickens marks a turning point in poultry breeding. It demonstrates that we can move beyond reactive approaches like mass culling and toward proactive, genetics-based disease prevention. If adopted carefully, with proper regulation and community engagement, this technology could transform poultry farming—especially in countries like India where smallholder livelihoods and national food security are deeply intertwined with animal health. The journey from laboratory to farm will not be simple, but it is one well worth taking. Because in a world where both animals and people are vulnerable to shared diseases, stronger poultry means a safer future for everyone.

References

Gallala, M. (2025). Application of CRISPR/Cas gene editing for infectious disease control in poultry. Open Life Sciences, 20(1), 20251095.

Mitchell, E., Tellez Jr, G., & McGrew, M. J. (2023). Chicken genome editing for investigating poultry pathogens. Avian Pathology, 52(1), 1-11.

Vilela, J. A. (2023). Development of CRISPR/Cas9-based Novel Vaccines against Poultry Viruses (Doctoral dissertation, Lancaster University (United Kingdom)).

Lee, J., Kim, D. H., & Lee, K. (2020). Current approaches and applications in avian genome editing. International Journal of Molecular Sciences, 21(11), 3937.

Ballantyne, M., Doddamani, D., & McGrew, M. J. (2020). The use of genome editing in poultry breeding. In Advances in poultry genetics and genomics (pp. 523-540). Burleigh Dodds Science Publishing.